LAUREN KESSENICH: Open Payments
NPI 1952830093 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 98 payments from 19 companies in 2025. Trend: 2023 $3,118 · 2024 $2,178 · 2025 $2,065
Food & beverage: $2,065
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $306 |
| Janssen Biotech, Inc. | 11 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $229 |
| Madrigal Pharmaceuticals | 10 | $181 |
| GENZYME CORPORATION | 7 | $149 |
| QOL Medical, LLC | 4 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Gilead Sciences, Inc. | 4 | $107 |
| Phathom Pharmaceuticals, Inc. | 5 | $104 |
| Ardelyx, Inc. | 5 | $95 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, RINVOQ, ENTYVIO, Sucraid, VOQUEZNA, IBSRELA.
Industry payments across FL — which companies pay providers there.
